WTI Crude Oil

THESIS HEALTH: CONFIRMED AND INTACT (seventh consecutive week at elevated levels). WTI at $111.54, WoW +0.00% — consolidating at elevated levels. Rate of change: STABLE/CONSOLIDATING, the prior +8.85% 1W in FRED data (vs WTI_AV $111.54 unchanged) reflects timing discrepancy — the FRED weekly spot at $104.69 (+8.85% 1W from ~$96) vs the current market WTI_AV at $111.54 suggests further price appreciation beyond the FRED data vintage. KEY DATA: (1) WTI $111.54 (market price as of 2026-04-02), FRED WTI $104.69 +8.85% 1W — rate of change: ACCELERATING from prior week consolidation, new operational escalation catalyst. (2) Brent $121.88 +7.49% 1W — Brent/WTI spread near $10, consistent with Hormuz-specific risk pricing (Brent more exposed to Middle East disruption routes). (3) 5Y breakeven 2.57% (+0.39% 1W, RISING) confirming energy-driven inflation expectations are re-pricing upward. Operation Epic Fury named military operation against Iran with 2-3 week timeline is the NEW INFORMATION this cycle — this upgrades the probability of sustained disruption vs prior. COUNTER-THESIS: The diplomatic parallel track is the most dangerous assumption. Trump simultaneously threatening and negotiating is his established bargaining pattern — there is a non-trivial probability that the 2-3 week 'operational' window is designed to extract a negotiated settlement rather than achieve physical destruction of Iranian capabilities. If Iran agrees to nuclear/regional terms, WTI could fall $20-30 in days. The second dangerous assumption is that OPEC+ won't coordinate an emergency production response — Saudi Arabia has $85-90 fiscal breakeven and benefits from higher prices, but US political pressure on Saudi/UAE is real and difficult to model. PAYOFF ASYMMETRY: If right (sustained Hormuz premium): WTI $115-130 = +3-17% from $111. If Hormuz closure: WTI $140-170 = +25-53%. If wrong (de-escalation): WTI $85-95 = -15-24%. With 50+20% probability on sustain/escalation vs 20% de-escalation: expected value is strongly positive. R/R: Escalation tail (20%) adds disproportionate upside; de-escalation (20%) is the full-thesis invalidator. Net R/R approximately 2.5:1.

Recent Data